Oncolinx Company
Oncolinx is developing antibody-drug conjugates.
Technology:
Others
Industry:
Gene therapy
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2013-01-01
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
1057283
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership